Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

News on a Synthes sentencing, Riata recall and other regulatory developments.


Related Content

Lack Of Device Identifiers On Recalled Cardiac Devices Cost Medicare $1.5Bn, OIG Says
News Briefs: Panel Supports Cochlear Implant; ReShape Duo Trial Update; Medtronic’s D-fib Lead Software
News In Brief
Ortho Panel Endorses Class II Status For Posterior Cervical Screws
St. Jude Stops Selling CRT Leads Showing Riata-Like Insulation Abrasion
News In Brief
FDA Approves St. Jude’s Quadripolar CRT-D Device Following Delay
Former Synthes Execs Get Prison Time For Unauthorized Spine Trial
FDA Urges Centralized Clinical Trial Monitoring Over Frequent On-Site Visits – Guidance
Group Calls For Public-Private Partnership To Develop Value-Driven Devices





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts